Now let me finalize the score and decision. I'll write the complete consolidated review.

## Calibration Summary

**Round 1 — Bracketing:**
- Low bracket (< 3.5): HealthSLM-Bench (1.50), UQ paper (2.50), LRL MT (2.67) — all withdrawn/rejected with limited contributions. Current paper is stronger.
- Middle bracket (3.5–7.5): C-SRRG (4.00), QRad (4.00), CoT in clinical text (4.50) — all rejected with methodological concerns.
- High bracket (> 7.5): Mostly unrelated topics (transduction, multi-turn conversation).

**Initial bracket:** 3.5–5.5

**Round 2 — Narrowing (read in full):**
- HealthSLM-Bench (1.50): Similar SLM benchmarking topic but no collapse analysis, much weaker. Current paper clearly stronger.
- C-SRRG (4.00): Similar tier — has a clear contribution but execution issues. Current paper comparable.
- QRad (4.00): Novel reframing contribution but execution concerns. Similar tier.
- Sensitivity of SLMs (4.00, Reject): Systematic study with clear findings but methodological concerns about realism of perturbations. Very similar profile to current paper.
- CoT Fails in Clinical Text (4.50, Reject): Large-scale evaluation with fair comparisons; slightly stronger methodologically than current paper.

**Final assessment:** The paper has a conceptually interesting collapse analysis but the unfair comparison (LoRA-tuned small LMs vs ICL-only large LMs) and underspecified methodology are significant weaknesses. Comparable to the ~4.0 rejected anchors.

---

## Final Review

## Summary

This paper evaluates small LMs (≤3B parameters) and small VLMs against larger, medically-adapted models on clinical text summarization (MeQSum) and radiology report generation (MIMIC-CXR). The authors conduct zero-shot, few-shot, and PEFT-based comparisons, and propose a "collapse analysis" framework with four dimensions (Task Adherence, Hallucination Rate, Concept Recall, Prompt Robustness) to identify a minimum viable scale for safe deployment. The headline observation is a sharp increase in hallucination rates at sub-billion parameter scales.

## Strengths

- **Collapse analysis provides concrete evidence of a safety threshold**: Table 3 shows hallucination rates spiking from 2–3% at ≥1B parameters to 18.3% (SmolLM2-360M) and 75% (Gemma-3-270M), with corresponding drops in Task Adherence and Concept Recall. The concept of a "safety collapse" at sub-billion scales is practically important for deployment decisions.

- **Multi-family evaluation across diverse architectures**: The paper evaluates three LM families (SmolLM2, Gemma-3, LLaMA-3.2) and two VLM families (Florence 2, Qwen 2.5-VL) at multiple parameter sizes, providing broader empirical coverage than single-architecture studies.

- **Fair zero-shot comparisons (Table 2) produce interesting findings**: SmolLM2-1.7B achieves competitive BERTScore (0.9007) and MEDCON (0.271) against large medical LMs like OpenBioLLM-8B (0.8938, 0.336) in a controlled ICL-only setting, demonstrating genuine efficiency.

- **Clear practical framing**: The paper thoughtfully positions SLMs for context-grounded information extraction rather than open-ended clinical reasoning, and explicitly acknowledges privacy/deployment advantages.

## Weaknesses

### Major

- **LoRA-tuned small LMs compared against ICL-only large LMs (Figure 3) — confound between adaptation method and model size**: The paper claims "after LoRA fine-tuning, all small LMs outperformed large LMs across every metric." However, the large LMs (BioMistral-7B, Med-LLaMA-8B, OpenBioLLM-8B) were evaluated only via in-context learning (zero/few-shot), while the small LMs received task-specific LoRA fine-tuning on the MeQSum training data. Figure 3 explicitly shows "-" for LoRA scores on all large models. This confound means the headline comparison conflates adaptation method with model size. A fair comparison would require either (a) fine-tuning large LMs with LoRA under identical conditions, or (b) comparing both families in the same inference regime. The paper does not acknowledge this asymmetry as a limitation.

- **VLM baseline adaptation status is unclear (Table 4)**: The paper describes fine-tuning Florence 2 (0.77B) and Qwen 2.5-VL (3B) on 10,000 MIMIC-CXR pairs, then compares them against Med-Flamingo (9B) and LLaVA-Med (7B) — but never states whether the large VLMs were also fine-tuned or evaluated zero-shot. If the large VLMs were not fine-tuned, the comparison is again confounded. If they were fine-tuned, the training setup must be described. As written, the comparison is uninterpretable.

- **Collapse analysis methodology is critically underspecified (Table 3)**: The four dimensions (Task Adherence, Hallucination Rate, Concept Recall, Prompt Robustness) and the "Readiness Score" are introduced without any formal definition or computation pipeline. There is no description of what annotators or automatic tools were used, how hallucinations were detected, how prompts were varied for robustness testing, or how the Readiness Score is aggregated. Without this information, the numerical results in Table 3 cannot be independently interpreted or reproduced. Additionally, "SmolLM3-3B" appears in Table 3 while the paper's model list (Table 1) and all other references use "SmolLM2" — this nomenclature error further undermines trust in the data.

### Minor

- **No confidence intervals or significance tests**: Results are reported as point estimates on a 250-sample test set without standard deviations, confidence intervals, or statistical significance tests. This makes it impossible to assess whether observed differences (e.g., SmolLM2-1.7B's 0.9007 BERTScore vs. OpenBioLLM-8B's 0.8938) are meaningful.

- **Nomenclature inconsistencies**: "SmolLM3-3B" vs. "SmolLM2" (Table 3); "MeQ-Small" vs. "MeQSum" (Section 4).

### Trivial

- None identified beyond the nomenclature issues already noted.

## Nice-to-Haves

- Fine-tune the large LMs (BioMistral-7B, Med-LLaMA-8B, OpenBioLLM-8B) with LoRA on the same training data to enable a fair comparison. This would either strengthen or clarify the paper's central claim about small LMs rivaling large ones.
- Provide a formal, reproducible definition and computation pipeline for each collapse dimension (Task Adherence, Hallucination Rate, etc.), including sample sizes, annotator details, and inter-rater reliability metrics if human evaluation was used.
- Report variance across prompt variants and test samples (e.g., standard deviations or bootstrap confidence intervals).
- Explicitly state whether Med-Flamingo and LLaVA-Med were fine-tuned on the same 10k MIMIC-CXR pairs; if not, report their zero-shot performance and acknowledge the confound.

## Removed Points

- **Decoding strategy specification (harsh critic)**: The paper states "three stochastic decoding strategies: top-k sampling with k=3, nucleus (top-p) sampling with p=0.9, and temperature sampling at T=0.3." These are standard combined hyperparameters for text generation, not three separate strategies used one at a time. This is a misreading, not a paper error. Removed.

- **Generic concerns about dataset size (harsh critic)**: The 250-sample test set criticism is fair as part of the "no confidence intervals" point but is not independently a weakness (250 samples is reasonable for a held-out test set in clinical NLP). Incorporated into the CIs point above.

- **Abstract/Introduction framing criticisms (harsh critic)**: These are downstream consequences of the unfair comparison issue already listed. Not a separate weakness.

- **"ICL-only comparison is unfair" vs. strength (Strength Finder point 2)**: The Strength Finder's point 2 (LoRA-tuned small LMs outperforming large LMs) conflicts with the verified weakness about unfair comparison. Per instructions, when strengths and weaknesses conflict, the weakness wins. This strength is demoted because the comparison is confounded.

## Novel Insights

**Collapse asymmetry across modalities**: The paper reveals an interesting asymmetry that merits deeper investigation — small LMs with LoRA can match large medical LMs on text summarization, yet small VLMs lag behind large VLMs on radiology report generation even with fine-tuning. If confirmed under fair comparisons (all models fine-tuned or all evaluated ICL), this would suggest that visual-semantic reasoning has a steeper scale-efficiency curve than text-only summarization, potentially because visual grounding demands richer representations that cannot be fully compensated by lightweight adapters. This is the paper's most intriguing finding, though it is weakened by the ambiguous VLM baseline status.

## Suggestions

1. **Run controlled comparisons**: Fine-tune all LMs (small and large) with identical LoRA configurations on the same training data. This single change would determine whether the paper's core claim about small LMs rivaling large ones holds under fair conditions. If it does, the paper is significantly strengthened; if not, the narrative should shift accordingly.

2. **Formalize the collapse analysis**: Provide pseudocode or explicit formulas for each dimension. Specify whether metrics are computed automatically (and via what tool/lexicon) or via human annotation (and with what inter-annotator agreement). Clarify the Readiness Score aggregation.

3. **Fix nomenclature**: Correct "SmolLM3-3B" to the appropriate model name; harmonize "MeQ-Small" → "MeQSum."

4. **Add statistical rigor**: Report means with standard deviations or bootstrap 95% CIs for all metrics across the 250 test samples.

## Score and Decision

**Round 1 bracket:** 3.5–5.5

**Round 2 narrowing anchors (read in full):**
- HealthSLM-Bench (1.50): Withdrawn. Much weaker — no collapse analysis, basic evaluation only. Current paper is stronger.
- C-SRRG (4.00, Reject): Similar tier — dataset contribution but limited novelty. Current paper comparable in contribution level.
- QRad (4.00, Reject): Novel reframing but execution issues. Similar tier.
- Sensitivity of SLMs (4.00, Reject): Systematic empirical study with methodological concerns. Very similar profile — interesting findings undermined by confounds in experimental design.
- CoT Fails in Clinical Text (4.50, Reject): Large-scale evaluation with fairer comparisons; methodologically stronger but conceptually narrower.

The paper is positioned at the lower end of the middle bracket — comparable to rejected papers at ~4.0. The collapse analysis is a genuine conceptual contribution, but the confounded comparisons undermine the headline claims, and the underspecified methodology prevents independent verification of the collapse findings.

MY FINAL SCORE: <score>4.0</score>
MY FINAL DECISION: <decision>Reject</decision>